Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Incorporation of paclitaxel in mesenchymal stem cells using nanoengineering upregulates antioxidant response, CXCR4 expression and enhances tumor homing

Materials Today Bio(2023)10.1016/j.mtbio.2023.100567Source: DataRank Database

Incorporation of paclitaxel in mesenchymal stem cells using nanoengineering upregulates antioxidant response, CXCR4 expression and enhances tumor homing is a research paper published in Materials Today Bio (2023). On theSindex it has a DataRank of 0. It has been cited 10 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access10 citations

Download PDF

Cite:

Linked data & code

doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.65)OA: goldTopics (17)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Carmen Merali ORCID,Drishti Sehgal,Émmanuelle Nicolas ORCID,Nitu Bhaskar,Magda Flores

Live enrichment

PubMed:36747581 PMC:PMC9898454 OpenAlex:https://openalex.org/W4318473358

NIBIB NIH HHS

Grant: R01 EB019893

American Cancer Society

Grant: RSG-22-123-01-ET

National Institutes of Health

Grant: EB220558

Temple University

FWCI

1.65

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://doi.org/10.1016/j.mtbio.2023.100567

publisherhttps://doi.org/10.1016/j.mtbio.2023.100567

repositoryhttps://pubmed.ncbi.nlm.nih.gov/36747581

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/9898454

repositoryhttps://doaj.org/article/fd99184c8f4c45d48e754b40cbaaca3f

Fields of Study

Mesenchymal stem cell researchAutophagy in Disease and TherapyCancer, Hypoxia, and Metabolism

Keywords

Mesenchymal stem cellHoming (biology)Downregulation and upregulationCell biologyOxidative stressChemistryCancer researchBiologyBiochemistryDrug resistanceMesenchymal Stem CellsTargeted Drug DeliveryNanoengineeringTumor Homing

Sustainable Development Goals

SDG 0: Good health and well-being

Incorporation of paclitaxel in mesenchymal stem cells using nanoengineering upregulates antioxidant response, CXCR4 expression and enhances tumor homing

FAIR Checklist

Authors (11)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)